Organon

​The decision of when—and whether—to start a family is one of the most important choices a woman can make.However, nearly half of all pregnancies worldwide (approximately 121 million annually) are estimated to be unplanned, leading to health risks and reduced educational and employment opportunities for mother and child – challenges which can span generations.Unplanned pregnancies are in part caused by a lack of access to contraceptive information and services. Globally, of the 257 million women who want to avoid pregnancy, almost 67% are not using any contraceptive method.Together with other organizations, we’re working to change this and help women and girls achieve their promise.Our multi-year global initiative “Her Plan is Her Power” aims to fuel global action and community-led responses to reduce unplanned pregnancy in areas where need is great and disparities exist, with a focus on innovation, education, access and advocacy. “Her Plan is Her Power” builds on existing programming launched in 2022 through our “Her Promise” ESG platform, with new funding to support:These new programs join the following existing collaborations and investments to address unplanned pregnancy:“Organon is proud to launch ‘Her Plan is Her Power’ and work with others to focus our resources and target responses to help ensure all women and girls can plan their future.”Kevin Ali, CEO of OrganonThe original article was published here.

​Organon has been recognized in Bloomberg’s 2023 Gender Equality Index (GEI), a benchmark indicator which tracks the performance of public companies committed to disclosing their efforts to support gender equality. Bloomberg’s 2023 GEI is based on data submitted through the Bloomberg reporting framework and associated with the fiscal year 2021.The 2023 GEI comprises 485 companies in 45 countries and regions across 11 sectors and 54 industries. The index measures gender equality across five pillars:Leadership & Talent PipelineEqual Pay & Gender Pay ParityInclusive CultureAnti-Sexual Harassment PoliciesExternal Brand“Our high benchmark scores are particularly noteworthy for a company less than two years old,” said Geralyn Ritter, Executive Vice President of External Affairs and ESG, Organon. “And we are just getting started! We’re committed to making gender equity a reality – both inside and outside our business, and for women and girls around the world.” The original article was published here.

Recognition highlights our leadership in expanding access to contraceptive choice.Organon was founded with a commitment to helping women achieve their promise through better health, which in turn, improves women’s agency, education, and labor force participation. To achieve this, we are tackling key health issues today – such as preventing millions of unintended pregnancies, which too often limit education and employment opportunities for mother and child – challenges that can span generations – so that we can ensure that women are a fixture in the global economy of tomorrow.It’s this bold commitment to women that earned Organon a spot on Fortune’s annual Change the World list, which recognizes companies that have had a positive social impact through activities that are part of their core business strategy.​“Organon is deeply honored to receive this recognition from Fortune. We are proud to be playing our part to help women and girls around the world achieve their promise through better health, including preventing 120 million unintended pregnancies by 2030.”Kevin AliCEO, Organon​Organon was recognized for our efforts to increase access to contraceptive choice globally through our portfolio of programs, collaborations, and investments designed to lift women and girls for generations to come through family planning education and contraceptive access:For more details on Organon’s ESG strategy, goals, and initiatives, download the full 2022 ESG Report athttps://www.organon.com/about-organon/environmental-social-governance/.The article was originally published here.